Syntermed Inc. has been awarded 510(k) clearance for Emory Cardiac Toolbox version 4.0. "One of the many things that makes Emory Toolbox 4.0 different is SmartReport, the first-ever, cloud-based nuclear cardiology reporting tool using decision support,” said Michael Lee, CEO, Syntermed Inc. The decision support system that powers SmartReport is called Syntermed IDS and will allow diagnosticians to perform faster, more accurate nuclear cardiology reports from single photon emission computed tomography (SPECT) and positron emission tomography (PET) heart scans.

At an event held at Hospital for Special Surgery, GE Healthcare introduced Mavric SL, a novel magnetic resonance (MR) imaging technique designed to address the growing clinical need to more accurately image soft tissue and bone in patients with MR conditional-labeled implants, such as joint replacements and other instrumentation. According to a Hospital for Special Surgery study published in The Journal of Bone & Joint Surgery, MR imaging can detect inflammation of the joint lining (synovitis) in patients with metal-on-metal hip implants long before symptoms appear, allowing for a more conclusive diagnosis and effective planning for follow-up care.

Positron Corp. announced the release of the PosiRx 3000-Series, its latest pharmacy automation systems. The PosiRx 3000-Series are the first systems to automate and encompass the complete compounding process, from generator elution to dose distribution, of multiple diagnostic SPECT agents in an environment engineered to be ISO Class 5 and USP 797 compliant. Designed for facilities dispensing as many as 300 patient-specific doses per day, the PosiRx 3000-Series will benefit providers and patients by enabling unit dose radiopharmaceuticals to be prepared more cost effectively and accurately than previously possible.

In March, RaySearch Laboratories AB announced that version 3.5 of RaySearch's RayStation treatment planning system had been released for clinical use. RaySearch has now received 510(k) clearance from the FDA for RayStation 3.5 meaning that the new features can be marketed in the U.S.

Olympus announced the company's ultrasound endoscopes will now be powered by the ProSound F75 Ultrasound Processor.The ProSound F75 Ultrasound Processor, developed in partnership by Hitachi Aloka Medical Ltd., provides physicians with the highest quality imaging that aids in more accurate diagnosis of diseases of the gastrointestinal (GI) tract and surrounding organs such as the pancreas, bile duct, liver, spleen and gallbladder as well as assessing a variety of cancers. The newly introduced platform improves workflow from pre-examination to after examination for better data management and provides improved visualization for more accurate blood flow information.